Last updated on February 2020

Effects of Oral Sildenafil on Mortality in Adults With PAH

Brief description of study

This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day [TID]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.

Clinical Study Identifier: NCT02060487

Find a site near you

Start Over